Zdrowie i gospodarka · 10/02/2016
FDA Hosts Public Workshop to Advance Biomarker Development for Traumatic Brain Injury
The FDA is hosting a public workshop to discuss potential biomarkers for traumatic brain injury, gather input from stakeholders, and establish strategies for data standardization and analysis to improve diagnosis and treatment.